Recent Androgen Receptor Antagonists in Prostate Cancer

被引：3
|
作者：
Lu, Xufang [1 ]
Dun, Kang [1 ]
Wang, Yang [1 ]
Yang, Yong [2 ]
You, Qidong [1 ]
Li, Zhiyu [1 ]
机构：
[1] China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, State Key Lab Nat Med, Nanjing 210009, Peoples R China
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 08期
基金：
中国国家自然科学基金;
关键词：
Androgen receptor; castration-resistant prostate cancer; prostate cancer; BIOLOGICAL EVALUATION; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE AKR1C3; DESIGN; DERIVATIVES; INHIBITORS; DOMAIN; ACID;
D O I：
10.2174/1389557514666140622203207
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Androgen receptor has been shown to promote prostate cell growth and carcinogenesis of prostate cancer by up-regulating its target genes. Testosterone and dihydrotestosterone are two major hormones which bind to and activate androgen receptor. Targeting both the androgen receptor and the enzymes catalyzing the biosynthesis of testosterone and dihydrotestosterone has been shown to be clinically beneficial in the treatment of prostate cancer. Prostate cancer can become castration-resistant after long term treatment with chemo drugs, so efforts in finding compounds with improved efficiency to castration-resistant prostate cancer are urgently needed. In this review we summarized the studies on recent progress in the development of small molecular AR antagonists for the treatment of prostate cancer.
引用
收藏
页码：655 / 663
页数：9
相关论文
共 50 条
  • [1] Androgen receptor antagonists for prostate cancer therapy
    Helsen, Christine
    Van den Broeck, Thomas
    Voet, Arnout
    Prekovic, Stefan
    Van Poppel, Hendrik
    Joniau, Steven
    Claessens, Frank
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : T105 - T118
  • [2] Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer
    Rathkopf, Dana
    Scher, Howard I.
    CANCER JOURNAL, 2013, 19 (01): : 43 - 49
  • [3] Recent Developments in Androgen Receptor Antagonists
    Ran, Fansheng
    Xing, Hualu
    Liu, Yang
    Zhang, Daoguang
    Li, Pengzhan
    Zhao, Guisen
    ARCHIV DER PHARMAZIE, 2015, 348 (11) : 757 - 775
  • [4] Second generation androgen receptor antagonists and challenges in prostate cancer treatment
    Chen, Yanhua
    Zhou, Qianqian
    Hankey, William
    Fang, Xiaosheng
    Yuan, Fuwen
    CELL DEATH & DISEASE, 2022, 13 (07)
  • [5] Resistance to second-generation androgen receptor antagonists in prostate cancer
    Keith T. Schmidt
    Alwin D. R. Huitema
    Cindy H. Chau
    William D. Figg
    Nature Reviews Urology, 2021, 18 : 209 - 226
  • [6] Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
    Culig, Zoran
    CANCERS, 2021, 13 (12)
  • [7] Resistance to second-generation androgen receptor antagonists in prostate cancer
    Schmidt, Keith T.
    Huitema, Alwin D. R.
    Chau, Cindy H.
    Figg, William D.
    NATURE REVIEWS UROLOGY, 2021, 18 (04) : 209 - 226
  • [8] Current androgen receptor antagonists under investigation for resistant prostate cancer
    Nigro, Maria Concetta
    Mollica, Veronica
    Marchetti, Andrea
    Cheng, Michael
    Rosellini, Matteo
    Montironi, Rodolfo
    Cheng, Liang
    Massari, Francesco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (02) : 191 - 202
  • [9] Second generation androgen receptor antagonists and challenges in prostate cancer treatment
    Yanhua Chen
    Qianqian Zhou
    William Hankey
    Xiaosheng Fang
    Fuwen Yuan
    Cell Death & Disease, 13
  • [10] In Silico Discovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate Cancer
    Shen, Howard C.
    Shanmugasundaram, Kumaran
    Simon, Nicholas I.
    Cai, Changmeng
    Wang, Hongyun
    Chen, Sen
    Balk, Steven P.
    Rigby, Alan C.
    MOLECULAR ENDOCRINOLOGY, 2012, 26 (11) : 1836 - 1846
12345